Wang Tong,Liu Yang,Zhu Yetao,Research development of bone mesenchymal stem cells for treating in tracerebral hemorrhage induced neurological dysfunction[J].SICHUAN MENTAL HEALTH,2019,32(6):573-576
Research development of bone mesenchymal stem cells for treating in tracerebral hemorrhage induced neurological dysfunction
DOI:10.11886/scjsws20181113003
English keywords:Intracerebral hemorrhage  Bone mesenchymal stem cells  Neural stem cells
Fund projects:四川省医学会资助项目 S16038;绵阳市卫计委资助项目 201615 201502;绵阳市第三人民医院资助项目(重点培育项目)四川省医学会资助项目(S16038);绵阳市卫计委资助项目(201615,201502);绵阳市第三人民医院资助项目(重点培育项目)
Author NameAffiliation
Wang Tong The Third Hospital of Mianyang·Sichuan Mental Health Center, Mianyang 621000, China 
Liu Yang The Third Hospital of Mianyang·Sichuan Mental Health Center, Mianyang 621000, China 
Zhu Yetao The Third Hospital of Mianyang·Sichuan Mental Health Center, Mianyang 621000, China 
Hits:
Download times:
English abstract:
      This review aims to elaborate the latest research development of bone mesenchymal stem cells in the treatment of neurological dysfunction after intracerebral hemorrhage. Intracerebral hemorrhage is a devastating disease that damages brain tissue, causing a heavy public health burden worldwide. The disease is characterized by high disability rate and high mortality, and the treatment is not effective. Direct differentiation into neurons and their functional characteristics of bone mesenchymal stem cells after transplantation makes it become a new choice for treating intracerebral hemorrhage.
View Full Text   View/Add Comment  Download reader
Close